Donna L. Sheedy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Donna L. Sheedy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Andrew H. Fortis
From the Department of Pathology, University of Sydney, NSW, Australia
2 shared publications- Clive Harper
Dept of Pathology, University of Sydney, Australia
2 shared publications - Therese M. Garrick
The University of Sydney
2 shared publications - Antony Harding
The New South Wales Tissue Resource Centre, Discipline of Pathology, The University of Sydney, NSW 2006, Australia
1 shared publication C. Harper
Discipline of Pathology, University of Sydney, Sydney, Australia
1 shared publicationC. Hunt
Discipline of Pathology, University of Sydney, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 23 January 2009
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 10 (1) , 366-384
The Importance of Brain Banks for Molecular Neuropathological Research: The New South Wales Tissue Resource Centre Experience
New developments in molecular neuropathology have evoked increased demands for postmortem human brain tissue. The New South Wales Tissue Resource Centre (TRC) at The University of Sydney has grown from a small tissue collection into one of the leading international brain banking facilities, which operates with best practice and quality control protocols. The focus of this tissue collection is on schizophrenia and allied disorders, alcohol use disorders and controls. This review highlights changes in TRC operational procedures dictated by modern neuroscience, and provides examples of applications of modern molecular techniques to study the neuropathogenesis of many different brain disorders.
- 23 January 2009
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 10 (1) , 366-384
Open AccessThe Importance of Brain Banks for Molecular Neuropathological Research: The New South Wales Tissue Resource Centre Experience
New developments in molecular neuropathology have evoked increased demands for postmortem human brain tissue. The New South Wales Tissue Resource Centre (TRC) at The University of Sydney has grown from a small tissue collection into one of the leading international brain banking facilities, which operates with best practice and quality control protocols. The focus of this tissue collection is on schizophrenia and allied disorders, alcohol use disorders and controls. This review highlights changes in TRC operational procedures dictated by modern neuroscience, and provides examples of applications of modern molecular techniques to study the neuropathogenesis of many different brain disorders.
- 10 June 2008
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 9 (3) , 205-216
An Australian Brain Bank: a critical investment with a high return!
Research into neuropsychiatric disorders, including alcohol-related problems, is limited in part by the lack of appropriate animal models. However, the development of new technologies in pathology and molecular biology means that many more questions can be addressed using appropriately stored human brain tissues. The New South Wales Tissue Resource Centre (TRC) in the University of Sydney (Australia) is a human brain bank that can provide tissues to the neuroscience research community studying alcohol-related brain disorders, schizophrenia, depression and bipolar disorders. Carefully standardised operational protocols and integrated information systems means that the TRC can provide high quality, accurately characterised, tissues for research. A recent initiative, the pre-mortem donor program called “Using our Brains”, encourages individuals without neuropsychiatric illness to register as control donors, a critical group for all research. Community support for this program is strong with over 2,000 people registering their interest. Discussed herein are the protocols pertaining to this multifaceted facility and the benefits of investment, both scientific and financial, to neuroscience researchers and the community at large.
- 10 June 2008
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 9 (3) , 205-216
An Australian Brain Bank: a critical investment with a high return!
Research into neuropsychiatric disorders, including alcohol-related problems, is limited in part by the lack of appropriate animal models. However, the development of new technologies in pathology and molecular biology means that many more questions can be addressed using appropriately stored human brain tissues. The New South Wales Tissue Resource Centre (TRC) in the University of Sydney (Australia) is a human brain bank that can provide tissues to the neuroscience research community studying alcohol-related brain disorders, schizophrenia, depression and bipolar disorders. Carefully standardised operational protocols and integrated information systems means that the TRC can provide high quality, accurately characterised, tissues for research. A recent initiative, the pre-mortem donor program called “Using our Brains”, encourages individuals without neuropsychiatric illness to register as control donors, a critical group for all research. Community support for this program is strong with over 2,000 people registering their interest. Discussed herein are the protocols pertaining to this multifaceted facility and the benefits of investment, both scientific and financial, to neuroscience researchers and the community at large.
- 2 January 2003
- Published by Wiley in The American Journal on Addictions
- Vol. 12 (1) , 52-59
Changing Trends in Heroin‐Related Deaths in Sydney, Australia‐1995 to 1999
- 2 January 2003
- Published by Wiley in The American Journal on Addictions
- Vol. 12 (1) , 52-59
Changing Trends in Heroin‐Related Deaths in Sydney, Australia‐1995 to 1999
- 1 January 2003
- Published by Wiley in The American Journal on Addictions
- Vol. 12 (1) , 52-59
Changing Trends in Heroin-Related Deaths in Sydney, Australia-1995 to 1999
This 1997-1999 study replicates an earlier one (1995-1997) in which coronial cases were reviewed at the Department of Forensic Medicine in Australia. Ten percent of the 2945 cases were considered accidental illicit drug deaths, compared to 4% in the previous study. Heroin was associated with 90% of the deaths, but in only 17% of these cases as a single drug. Concomitant drug use, in particular alcohol, benzodiazepines, and antidepressants, has increased considerably. The combined effects of these substances might play a role in the disturbingly large increase in heroin (morphine) related deaths during this period.
- 1 January 2003
- Published by Wiley in The American Journal on Addictions
- Vol. 12 (1) , 52-59
Changing Trends in Heroin-Related Deaths in Sydney, Australia-1995 to 1999
This 1997-1999 study replicates an earlier one (1995-1997) in which coronial cases were reviewed at the Department of Forensic Medicine in Australia. Ten percent of the 2945 cases were considered accidental illicit drug deaths, compared to 4% in the previous study. Heroin was associated with 90% of the deaths, but in only 17% of these cases as a single drug. Concomitant drug use, in particular alcohol, benzodiazepines, and antidepressants, has increased considerably. The combined effects of these substances might play a role in the disturbingly large increase in heroin (morphine) related deaths during this period.